Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Biomarkers In Cerebrospinal Fluid

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Dementia

benzodiazepine1 - brain functions in patients1 - neurobiology1 - impaired memory1 - brain inflammation1 - functional activation studies1 - wernicke's disease10 - delay dementia1 - cognitive deterioration2 - bucknill1 - downs syndrome1 - tavi2 - vad2 - mci7 - sobrino1 - apolipoprotein1 - amyloid-beta peptides1 - degenerationist hypothesis1 - quantitative structural neuroimaging1 - alzheimer's plan1 - vascular damage1 - cognitive skills2 - advanced dementia1 - spect1 - tau tangles1 - memory loss20 - diagnosis of dementia1 - epidemiology1 - declines in memory1 - parkinson's patients5 -